New device aims to measure hidden heart stiffness
NCT ID NCT07215715
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This observational study tests a new device (eMyosound LYRA) that uses sound waves to measure stiffness in the heart and liver. Researchers will compare 150 people—some with heart failure, some with a rare heart condition called ATTR-CM, and some healthy volunteers. The goal is to see if this non-invasive tool can help doctors better understand and diagnose these conditions.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ATTR-CM (TRANSTHYRETIN AMYLOID CARDIOMYOPATHY) are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Boston Medical Center
RECRUITINGBoston, Massachusetts, 02118, United States
-
Brigham and Women's Hospital
RECRUITINGBoston, Massachusetts, 02116, United States
-
Massachusetts General Hospital
RECRUITINGBoston, Massachusetts, 02114, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Liver clues: a new way to stage heart amyloidosis?
- A carpal tunnel clue to a silent heart threat?
- Heart scans may unlock hidden risks in minority communities
- Could a common blood pressure pill protect the heart after valve replacement?
- Pacemaker signals may unmask a rare heart condition
- Exercise as medicine: can a tailored workout program reduce hospital visits for heart failure patients?